Trend Analysis of Micro Cap Stocks – GEVO, VRNG, KERX, PAL
Houston, TX – Jan 8, 2013 — (Net PR News) – AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.
Today’s Stocks in focus are: NASDAQ:GEVO, NYSEAMEX:VRNG, NASDAQ:KERX, NYSEAMEX:PAL
Gevo, Inc. (NASDAQ:GEVO) declared that its Board of Directors has ratified a stock repurchase program that authorizes GEVO to repurchase almost $15,000,000 of its common stock over a one-year period. Any shares repurchased will be categorized as treasury stock or retired.
Get A Free Report And Detailed Analysis On GEVO CLICK HERE To Read
Gevo, Inc. (NASDAQ:GEVO) ended its day with the gain of 1.3% and closed at the price of $2.21 after opening at $2.21. The stock traded during its last trading session with the total traded volume of 3,295,800 shares, as compared to its average volume of 596,445.00 shares.
During the previous session, the company’s minimum price was $2.10 while it touched its highest price for the day at $2.43. During the last one month, the company gained 56.74% while its last 5 days shows an upsurge of 42.58%.
Vringo, Inc. (NYSEAMEX:VRNG) reported the gain of +9.34% and closed at $3.63 with the total traded volume of 2,786,200 shares. The stock’s opening price was $3.32. The company has a total of 80.33 million outstanding shares and its total market capitalization is $291.59 million.
The 52-week price range of the stock remained $0.68 – $5.73, while during last trade its minimum price was $3.18 and it gained its highest price of $3.63. The Company’s last 5 days shows an uptrend of 36.47%.
Can VRNG Extend This Gain? Find Out In This TREND ANALYSIS REPORT
Keryx Biopharmaceuticals (NASDAQ:KERX) stocks opened at $2.85 and, as day trade closed, its price was $2.92 after scoring +6.96% . The market capitalization of KERX was 210.02 million. Total traded volume of the stock was 2,580,400 shares, while the company’s average volume remained 1.29 million shares.
KERX’s day range remained $2.77 – $3.03 while its 52 week range was $1.28 – $5.19. The 5 days performance graph showed it as a percentage gainer with +14.51%.
How Should Investors React To KERX Now? Find Out In This TREND ANALYSIS REPORT
North American Palladium Ltd (USA) (NYSEAMEX:PAL) reported the increase of +6.00% to close at $1.59 with the overall traded volume of 2,481,400 shares. Its market capitalization was $277.78 million. Its beta value stands at 1.99 times and earning per share was $-0.43.
North American Palladium Ltd (USA) (NYSEAMEX:PAL) has the total of 174.70 million outstanding shares. During last trade, the company’s minimum price was $1.48 while it touched its highest price of $1.60.
The Company’s year to date performance remained quite optimistic with the rise of 22.31. If we look at its last 6 months of trade, that is in the bearish zone with the decline of -23.56%.
How Should Investors Trade PAL Now? Don’t Trade PAL Until You Read This TREND ANALYSIS REPORT
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.